Eve Holding, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Eve Holding, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($224.26M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($138.17M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | ($127.66M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | ($174.03M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | ($18.26M) | Mar 8, 2024 |
| FY2021 | Dec 31, 2020 | ($16.66M) | Feb 15, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($225.39M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($156.37M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | ($130.55M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | ($189.49M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | ($18.18M) | Mar 8, 2024 |
| FY2021 | Dec 31, 2020 | ($353.5K) | Feb 15, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $194.70M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $129.84M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $105.58M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $51.86M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $13.28M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $8.36M | May 4, 2023 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.69M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $26.53M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $23.10M | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $32.86M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $4.90M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $1.23M | May 4, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($160.43M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($135.97M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | ($94.51M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | ($59.46M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | ($14.89M) | Mar 8, 2024 |
| FY2021 | Dec 31, 2020 | ($310.1K) | Feb 15, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.56M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $5.22M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $168.0K | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | $476.0K | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $0 | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $0 | May 4, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $434.88M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $318.24M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $245.34M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $312.88M | Mar 8, 2024 |
| FY2024 | Dec 31, 2021 | $21.57M | Mar 11, 2025 |
| FY2021 | Dec 31, 2020 | $234.58M | Feb 15, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $311.12M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $194.32M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $80.29M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $25.95M | Mar 8, 2024 |
| FY2024 | Dec 31, 2021 | $10.87M | Mar 11, 2025 |
| FY2021 | Dec 31, 2020 | $48.46M | Feb 15, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.76M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $123.92M | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | $165.05M | Mar 16, 2026 |
| FY2025 | Dec 31, 2022 | $286.92M | Mar 16, 2026 |
| FY2024 | Dec 31, 2021 | $10.70M | Mar 11, 2025 |
| FY2023 | Dec 31, 2020 | ($1.01M) | Mar 8, 2024 |
| FY2021 | Aug 6, 2020 | $0 | Feb 15, 2022 |
| FY2022 | Dec 31, 2019 | ($479.2K) | May 4, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($707.09M) | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | ($482.84M) | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | ($344.67M) | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | ($217.01M) | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | ($42.98M) | May 4, 2023 |
| FY2021 | Dec 31, 2020 | ($46.18M) | Feb 15, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.23M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $56.37M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $46.88M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $49.15M | Mar 8, 2024 |
| FY2024 | Dec 31, 2021 | $14.38M | Mar 11, 2025 |
| FY2021 | Dec 31, 2020 | $1.97M | Feb 15, 2022 |
| FY2021 | Aug 6, 2020 | $0 | Feb 15, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $179.79M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | $132.01M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | $25.76M | Mar 11, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | 0 | May 4, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 16, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 16, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | 0 | May 4, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 348.30M | Mar 16, 2026 |
| FY2025 | Dec 31, 2024 | 297.64M | Mar 16, 2026 |
| FY2024 | Dec 31, 2023 | 269.36M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 269.09M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | 220.00M | May 4, 2023 |